An in vivo analysis of the endogenous SCLC tumors developing in the lungs of Rb/p53/p130–mutant mice after 30 days of treatment with imipramine revealed that imipramine-treated mice had fewer and smaller SCLC tumors than control mice. The gene discussed is RB1; the disease is small cell lung carcinoma.